Seema Verma, former CMS head, joins Oracle

Seema Verma, the former head of the Centers for Medicare and Medicaid Services (CMS) under the Trump administration, has joined Oracle as senior vice president and general manager of Life Sciences, the company announced. 

In this new role, Verma will lead the Oracle Life Sciences and Oracle Cerner Enviza lines of business. She most recently served as a senior advisor to private equity firms Cressy & Co. and TPG.

During her time at CMS, Verma was a proponent of healthcare transparency to give patients more information about their healthcare options. This included a rule that required hospitals to post the list prices of their most common procedures. She also served on the White House COVID-19 Task Force, helping in the widespread adoption of telehealth, Hospital at Home and no-cost vaccines for the entire country.

“Seema has a proven track record of success in both public and private sector healthcare,”  Mike Sicilia, executive vice president of Oracle Global Industries, said in a statement on April 20. “Because of this, she has a unique understanding of how to bring together those on the cutting edge of innovation and those in charge of regulation to help our customers make critical medical breakthroughs and bring new therapies to market.”

Prior to her time at CMS, Verma founded and sold a national consulting company and worked as a vice president for policy and planning for a public hospital, public health department, and health system. In addition, she served on the Board of Directors for Lumeris, Monogram, Wellsky, ClaimsXten, Lifestance and ShiftKey. 

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”